![Raymond Sanchez](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: - $ in data 30/06/2026
Attualmente, Raymond Sanchez occupa la posizione di Chief Medical Officer di Cerevel Therapeutics Holdings, Inc. Fa anche parte del consiglio di amministrazione della Connecticut Mental Health Center Foundation ed è co-presidente esecutivo della International Society for CNS Drug Development. Nella sua carriera passata ha occupato la posizione di Chief Medical Officer presso Avanir Pharmaceuticals, Inc. Raymond Sanchez si è laureato alla Northwestern University e ha conseguito il dottorato alla Feinberg School of Medicine.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 14/04/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| RAPPORT THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 07/11/2024 |
| ALTO NEUROSCIENCE, INC. | Direttore/Membro del Consiglio | 13/08/2025 |
Connecticut Mental Health Center Foundation | Direttore/Membro del Consiglio | - |
Yale School of Medicine
 Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Direttore/Membro del Consiglio | - |
Bain Capital Life Sciences LP
 Bain Capital Life Sciences LP Investment ManagersFinance Bain Capital Life Sciences invests in public and private companies located across the globe. The firm focuses on biopharmaceutical, specialty pharmaceuticals, medical device, diagnostic and life science technology sectors. It provides financing for buyout and growth stage capital requirements with an investment size of USD 25 - 100 million. | Investitore di Private Equity | 01/09/2024 |
| Società | Posizione | Fine |
|---|---|---|
| CEREVEL THERAPEUTICS HOLDINGS, INC. | Direttore Tecnico/Scientifico/R&S | 01/08/2024 |
International Society for CNS Drug Development
 International Society for CNS Drug Development Miscellaneous Commercial ServicesCommercial Services The non-profit company is based in San Diego, CA. It promotes collaboration among academia, industry, and government to address scientific challenges in CNS drug development. ISCDD provides resources such as the GRID-Hamilton Depression Rating Scale (GRID-HAMD), which separately rates symptom intensity and frequency, and the Medication Satisfaction Questionnaire (MSQ), both available for licensing and adaptable to various languages and settings. The organization also offers the Uncorrelated PANSS Score Matrix (UPSM™), an analytical tool for refining the assessment of schizophrenia symptoms. The society facilitates knowledge sharing through annual meetings. The International Society for CNS Drug Development (ISCDD) is a non-profit, independent organization founded in 2002 to advance methodologies in central nervous system (CNS) research. | Presidente | 01/01/2022 |
| AVANIR PHARMACEUTICALS INC | Direttore Tecnico/Scientifico/R&S | 01/01/2019 |
Otsuka Pharmaceutical Development & Commercialization, Inc.
 Otsuka Pharmaceutical Development & Commercialization, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products | Corporate Officer/Principal | 01/01/2019 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 11 |
|---|---|
Avanir Pharmaceuticals, Inc.
 Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic products for the treatment of nervous system disorder | Health Technology |
Otsuka Pharmaceutical Development & Commercialization, Inc.
Otsuka Pharmaceutical Development & Commercialization, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products | Health Technology |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
International Society for CNS Drug Development
International Society for CNS Drug Development Miscellaneous Commercial ServicesCommercial Services The non-profit company is based in San Diego, CA. It promotes collaboration among academia, industry, and government to address scientific challenges in CNS drug development. ISCDD provides resources such as the GRID-Hamilton Depression Rating Scale (GRID-HAMD), which separately rates symptom intensity and frequency, and the Medication Satisfaction Questionnaire (MSQ), both available for licensing and adaptable to various languages and settings. The organization also offers the Uncorrelated PANSS Score Matrix (UPSM™), an analytical tool for refining the assessment of schizophrenia symptoms. The society facilitates knowledge sharing through annual meetings. The International Society for CNS Drug Development (ISCDD) is a non-profit, independent organization founded in 2002 to advance methodologies in central nervous system (CNS) research. | Commercial Services |
Yale School of Medicine
Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Feinberg School of Medicine
 Feinberg School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bain Capital Life Sciences LP
Bain Capital Life Sciences LP Investment ManagersFinance Bain Capital Life Sciences invests in public and private companies located across the globe. The firm focuses on biopharmaceutical, specialty pharmaceuticals, medical device, diagnostic and life science technology sectors. It provides financing for buyout and growth stage capital requirements with an investment size of USD 25 - 100 million. | Finance |
Cerevel Therapeutics Holdings, Inc.
 Cerevel Therapeutics Holdings, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops novel therapies for neurological and psychiatric disorders | Health Technology |
Connecticut Mental Health Center Foundation | |
Alto Neuroscience, Inc.
 Alto Neuroscience, Inc. BiotechnologyHealth Technology Engages in psychiatric drug development | Health Technology |
Rapport Therapeutics, Inc.
 Rapport Therapeutics, Inc. BiotechnologyHealth Technology Operates as an clinical-stage biotechnology company that engages in discovery and development of medicines for neurological disorder | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
